1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.01, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

2. The information in this report is based on a plan statement dated as of December 31, 2018.

Remarks:

/s/ Jennifer R. Guckert, pursuant to a power of attorney

03/13/2019

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v).